Connection

Peter Verhamme to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Peter Verhamme has written about Combined Modality Therapy.
Peter Verhamme
Connection Strength
0.051
Combined Modality Therapy
  1. A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial. Trials. 2020 Nov 27; 21(1):981.
    View in: PubMed
    Score: 0.028
  2. European guidelines on perioperative venous thromboembolism prophylaxis: Mechanical prophylaxis. Eur J Anaesthesiol. 2018 Feb; 35(2):112-115.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.